#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15786	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2052	764.9	0	.	n	.	0	C451T	SNP	451	451	C	670	670	T	961	T,C	642,217	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15786	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2052	764.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	917	C,T	817,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15786	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2052	764.9	0	HET	.	.	.	C207T,A	.	207	207	C	426	426	C	826	C,T,A	558,189,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	0	.	n	.	0	T695C	SNP	695	695	T	831	831	C	974	C,T	874,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2107	2107	C	915	C	832	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2181	2181	A	859	A	778	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2733	2733	C	968	C	875	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1774	1774	A	982	A,G,T	684,196,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29186	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3180	907.4	0	HET	.	.	.	G2616A	.	2616	2616	G	2752	2752	G	980	G,A	691,182	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2204	folP	855	855	100.0	folP.l15.c4.ctg.1	1411	155.7	1	SNP	p	R229S	1	.	.	685	687	AGC	990	992	AGC	252;249;249	A;G;C	228;226;225	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6028	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3398	177.0	1	SNP	p	S91F	1	.	.	271	273	TTC	571	573	TTC	182;185;185	T;T;C	168;169;166	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6028	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3398	177.0	1	SNP	p	D95G	1	.	.	283	285	GGC	583	585	GGC	185;188;191	G;G;C	169;171;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6028	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3398	177.0	1	SNP	p	G95N	0	.	.	283	285	GGC	583	585	GGC	185;188;191	G;G;C	169;171;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1784	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1314	135.2	1	SNP	p	G45D	0	.	.	133	135	GGC	489	491	GGC	256;256;259	G;G;C	229;230;232	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	748	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	877	83.9	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	187	A	173	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5600	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2918	191.4	1	SNP	p	D86N	0	.	.	256	258	GAC	509	511	GAC	223;222;223	G;A;C	205;198;208	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5600	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2918	191.4	1	SNP	p	R87W	0	.	.	259	261	CGT	512	514	CGT	220;221;221	C;G;T	205;203;205	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5600	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2918	191.4	1	SNP	p	S87R	1	.	.	259	261	CGT	512	514	CGT	220;221;221	C;G;T	205;203;205	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5600	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2918	191.4	1	SNP	p	R87I	0	.	.	259	261	CGT	512	514	CGT	220;221;221	C;G;T	205;203;205	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5600	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2918	191.4	1	SNP	p	S88P	0	.	.	262	264	TCC	515	517	TCC	222;225;223	T;C;C	206;207;206	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5022	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2529	197.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1566	1568	GGC	242;239;239	G;G;C	222;218;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1287	1289	GCC	261;263;264	G;C;C,T	235;237;237,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1290	1292	ATG	263;269;268	A;T;G	237;242;239	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1302	1304	ACC	272;271;268	A;C;C	242;249;246	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1302	1304	ACC	272;271;268	A;C;C	242;249;246	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1803	1805	ACC	248;251;252	A;C;C	218;221;221	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1857	1859	GCG	244;249;239	G;C;G	218;222;216	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1857	1859	GCG	244;249;239	G;C;G	218;222;216	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1980	1982	GGT	221;219;218	G;G;T	191;191;191	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1989	1991	AGC	218;215;211	A,T;G;C,T	188,1;186;182,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4602	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2405	190.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2007	2009	CCG	177;184;184	C,G,T;C,G;G	133,7,1;141,2;144	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6174	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3096	198.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1592	1594	CCG	236;232;231	C;C;G	207;210;203	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2290	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1788	127.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	462	462	C	177	C	153	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3066	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1635	186.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1006	1008	AGA	227;221;222	A;G;A	212;205;208	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3066	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1635	186.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1027	1029	GGT	227;221;222	G;G;T	204;199;201	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3066	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1635	186.8	1	SNP	p	G120K	1	.	.	358	360	AAG	736	738	AAG	274;272;275	A;A;G	243;246;240	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3066	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1635	186.8	1	SNP	p	N121D	0	.	.	361	363	AAC	739	741	AAC	275;271;273	A;A;C	243;245;243	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3066	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1635	186.8	1	SNP	p	A121N	1	.	.	361	363	AAC	739	741	AAC	275;271;273	A;A;C	243;245;243	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11536	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4745	242.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1202	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	860	138.0	1	SNP	p	V57M	1	.	.	169	171	ATG	484	486	ATG	239;240;243	A;T;G	216;218;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
